Intermolecular failure of L-type Ca2+ channel and ryanodine receptor signaling in hypertrophy

Ming Xu1, Peng Zhou, Shi-Ming Xu

  • 1State Key Lab of Biomembrane and Membrane Biotechnology, Ministry of Education Key Lab of Molecular Cardiovascular Sciences and Institute of Vascular Medicine, Third Hospital, College of Life Sciences, Peking University, Beijing, China.

Plos Biology
|January 12, 2007
PubMed

Insights

Heart failure involves defects in calcium handling. This study reveals "intermolecular failure" in calcium signaling occurs early in compensated hypertrophy, preceding cellular damage and impacting heart function.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cell Physiology

Background:

  • Pressure overload leads to cardiac hypertrophy and heart failure.
  • Calcium handling, specifically calcium-induced calcium release (CICR), is crucial for heart contraction but is impaired in heart failure.
  • The precise molecular mechanisms underlying CICR defects during hypertrophy are not fully understood.

Purpose of the Study:

  • To investigate the intermolecular coupling between L-type calcium channels (LCCs) and ryanodine receptors (RyRs) during pressure overload-induced cardiac hypertrophy.
  • To determine if defects in this coupling precede or coincide with cellular dysfunction.
  • To elucidate the role of junctophilin in mediating LCC-RyR interactions.

Main Methods:

  • Utilized loose-patch confocal imaging in rat models of compensated (CHT) and decompensated (DHT) hypertrophy induced by aortic stenosis.
  • Quantified LCC-RyR coupling parameters including latency, chance of hit, and chance of miss.
  • Assessed junctophilin expression levels.

Main Results:

  • Decompensated hypertrophy (DHT) exhibited prolonged LCC-RyR coupling latency and reduced coupling efficiency, termed "intermolecular failure."
  • Compensated hypertrophy (CHT) also showed significant intermolecular failure, linked to decreased junctophilin expression, indicating it occurs before overt cellular changes.
  • Cell-wide calcium release (spikes) desynchronized in CHT, but cellular calcium transient integrity was maintained within a "stability margin."

Conclusions:

  • "Intermolecular failure" in calcium signaling is an early event in cardiac hypertrophy, preceding cellular dysfunction.
  • Decreased junctophilin expression contributes to this early intermolecular failure.
  • Cardiac excitation-contraction coupling maintains integrity within a stability margin, with global failure occurring only when this margin is exceeded, highlighting potential therapeutic targets.

Related Concept Videos

Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
108.9K
Relaxation of Skeletal Muscles01:29

Relaxation of Skeletal Muscles

The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
9.7K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
2.4K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
78